BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6201959)

  • 1. [Colorectal carcinoma. Diagnostic value of various biological markers in postoperative recurrences].
    Antón Aranda E; Martí Cabané J; Tiberio López G; Pérez Garciá C
    Rev Clin Esp; 1984 Jan; 172(2):69-73. PubMed ID: 6201959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?].
    Wedell J; Meier zu Eissen P; Meier zu Eissen J; Blanco A; van Calker H; Koldowski P; Schlipköter HW
    Med Welt; 1981 Mar; 32(11):343-7. PubMed ID: 7219141
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoembryonic antigen as a prognostic and monitoring test in colorectal carcinoma.
    Chatterji A; Batabyal SK
    Indian J Pathol Microbiol; 1987 Jan; 30(1):81-7. PubMed ID: 3679340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].
    Colombo PL; Lovotti D; Franco F; Coronelli M; Bonacasa R
    Minerva Med; 1986 Mar; 77(13):495-8. PubMed ID: 3703341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 6. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen in the management of colorectal cancer.
    Goldenberg DM
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):1-3. PubMed ID: 425796
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
    Metzger U; Decurtins M; Joller H; Grob PJ; Largiadèr F
    Schweiz Med Wochenschr; 1983 Apr; 113(15):548-9. PubMed ID: 6857209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of carcinoembryonic antigen in the treatment of colorectal cancers].
    Putzki H
    Zentralbl Chir; 1986; 111(18):1119-23. PubMed ID: 3788331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.
    Kohler JP; Simonowitz D; Paloyan D
    Am Surg; 1980 Aug; 46(8):449-52. PubMed ID: 7406353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 12. [The place and importance of oncofetal proteins and the hemocult test in searching for early recurrences following the radical surgical treatment of colorectal cancer].
    Viiachki I; Tokov P
    Khirurgiia (Sofiia); 1986; 39(5):109-13. PubMed ID: 3784395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic findings in patients with colorectal carcinoma. IV. Serum proteins as indicators of disease recurrence].
    Richter J; Hrbek M; Král V
    Rozhl Chir; 1986 Jul; 65(7):527-32. PubMed ID: 3764589
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
    Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
    Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
    Safi F; Rappenecker B; Roscher R; Beger HG
    Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of carcinoembryonic antigen in the detection of primary and recurrent colorectal carcinoma.
    Knoepp LF; McCulloch JH; Conn RL
    J S C Med Assoc; 1979 Jul; 75(7):311-3. PubMed ID: 288947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
    Young Tabusso F; Payet Meza E; Celis Zapata J; Ruiz Figueroa E; Berrospi Espinoza F
    Rev Gastroenterol Peru; 2002; 22(3):213-20. PubMed ID: 12378215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
    Arnaud JP; Koehl C; Adloff M
    Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.